Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • DrD2009
    Member
    • Oct 2009
    • 88

    #1

    Greetings from Kansas City

    Hello everyone,

    My name is Brandon Dinwiddie and I'm currently working as a bioinformatician in a laboratory at UMKC (University of Missouri - Kansas City). I graduated from my undergrad here at UMKC in May with a B.S. in Biology and B.A. in Chemistry and Psychology. I'm not entirely sure if this is the line of work I want to go into, I wanted to have more research experience under my belt before I made the decision of whether to go Ph.D. Biology or into a medical graduate program.

    I have no previous bioinformatic experience, only computer experience and even now I'm feeling those might have not been a good measurement of my bioinformatics capabilities, but I'd like to think I'm picking it up at a fairly decent rate.

    I'm not sure what else to mention, but I look forward to interacting with members of the forums. I know I'll certainly be asking my fair share of questions and I'm slowly starting to help some of my fellow bioinformaticians. If you have any questions for me feel free to ask. I'm usually pretty friendly.



    Cheers,
    Brandon

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...